PEPPOLONI, Samuele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.885
NA - Nord America 11.940
AS - Asia 5.854
SA - Sud America 649
AF - Africa 83
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 39.438
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.367
US - Stati Uniti d'America 11.771
SG - Singapore 2.239
GB - Regno Unito 2.160
CN - Cina 1.826
HK - Hong Kong 809
DE - Germania 713
SE - Svezia 650
FR - Francia 570
BR - Brasile 527
UA - Ucraina 330
RU - Federazione Russa 263
VN - Vietnam 242
TR - Turchia 223
FI - Finlandia 204
KR - Corea 134
BG - Bulgaria 120
MX - Messico 97
IN - India 92
NL - Olanda 81
AT - Austria 79
ID - Indonesia 62
AR - Argentina 59
PL - Polonia 51
RO - Romania 47
BE - Belgio 46
CA - Canada 46
JP - Giappone 37
IE - Irlanda 36
ZA - Sudafrica 33
CH - Svizzera 32
BD - Bangladesh 31
IQ - Iraq 30
ES - Italia 27
LT - Lituania 18
MA - Marocco 18
PT - Portogallo 18
IR - Iran 17
MY - Malesia 17
CZ - Repubblica Ceca 16
AE - Emirati Arabi Uniti 14
AU - Australia 14
EC - Ecuador 12
CO - Colombia 11
DK - Danimarca 10
VE - Venezuela 10
IL - Israele 9
CL - Cile 8
PK - Pakistan 8
PY - Paraguay 8
TH - Thailandia 8
TW - Taiwan 8
UZ - Uzbekistan 8
EU - Europa 7
HN - Honduras 7
KE - Kenya 7
AL - Albania 6
JO - Giordania 6
NO - Norvegia 6
PE - Perù 6
UY - Uruguay 6
EG - Egitto 5
KG - Kirghizistan 5
PA - Panama 5
AM - Armenia 4
CR - Costa Rica 4
DZ - Algeria 4
MT - Malta 4
PH - Filippine 4
RS - Serbia 4
SM - San Marino 4
SN - Senegal 4
TN - Tunisia 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HR - Croazia 3
LV - Lettonia 3
NP - Nepal 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AN - Antille olandesi 2
CG - Congo 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
Totale 39.422
Salva come PNG Salva come JPEG
Città #
Singapore 1.654
Southend 1.564
Santa Clara 1.383
Ashburn 907
Fairfield 855
Hong Kong 808
Chandler 781
Woodbridge 644
Hefei 631
Milan 623
Jacksonville 600
Rome 588
Houston 510
Bologna 449
Dearborn 446
Ann Arbor 444
Wilmington 347
Nyköping 335
Seattle 314
Beijing 306
Torino 290
London 275
Chicago 256
Los Angeles 248
Cambridge 229
Modena 227
Florence 226
New York 158
Catania 146
Seoul 127
Genova 125
Padova 118
Princeton 118
Sofia 116
Verona 116
Izmir 114
Dallas 107
Castelnuovo Rangone 105
Salt Lake City 105
Bremen 103
Eugene 102
Council Bluffs 101
Venezia 101
Moscow 98
Napoli 94
Des Moines 92
San Diego 92
Turin 92
Helsinki 90
Munich 88
Ho Chi Minh City 84
The Dalles 82
Pisa 81
Shanghai 81
Palermo 77
Reggio Nell'emilia 77
Redwood City 76
Nuremberg 74
Bari 71
Mexico City 67
Trento 66
Naples 65
Buffalo 63
Elk Grove Village 56
Trieste 56
Tampa 54
Hanoi 51
São Paulo 51
Bolzano 50
Parma 50
Piemonte 50
Boardman 48
Falls Church 47
Jakarta 46
Udine 46
Oggiono 45
Monza 44
Vienna 43
Norwalk 41
Genoa 40
Messina 39
Pavia 35
Nanjing 34
Tokyo 34
Brussels 33
Dublin 33
Rio Saliceto 33
Cagliari 32
Columbus 32
Mountain View 32
Frankfurt am Main 30
Reggio Emilia 30
Stockholm 30
Kent 28
Prato 28
Dolo 27
Phoenix 26
Bergamo 25
Ferrara 25
Guangzhou 25
Totale 20.841
Salva come PNG Salva come JPEG
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.200
Yessotoxin inhibits phagocytic activity of macrophages. 412
Ruolo della proteina pneumococcica di superficie PspC nel l’interazione in vitro di Streptococcus pneumoniae con le cellule microgliali 408
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 391
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 386
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 372
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 360
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 356
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 352
RUOLO BIOLOGICO DI DUE RECETTORI TOLL-SIMILI, TLR2 E TLR4, NELLA RISPOSTA MACROFAGICA A CANDIDA ALBICANS 343
Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library 334
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 327
La proteina di superficie PspC di pneumococco conferisce resistenza al killing in vitro di Streptococcus pneumoniae da parte di cellule microgliali in maniera indipendente dal complemento 326
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 323
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 323
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 319
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 308
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 307
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 293
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 284
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 281
Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia 275
Contribution of different pneumococcal virulence factors to experimental meningitis in mice 273
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. 264
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 264
Safety and immunogencity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study 263
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglial cells 261
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 261
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 260
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. 257
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 255
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 253
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 248
RUOLO DELLA SUPEROSSIDO DISMUTASI DI Enterococcus faecalis SULLA REATTIVITA’ DELLA MICROGLIA IN VITRO 245
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? 244
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 238
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 236
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement 234
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 229
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 229
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii 227
The TIGR4 strain of Streptococcus pneumoniae is phagocytosed but resists intracellular killing by microglia in experimental pneumococcal meningitis 227
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 225
New strategies for the prevention and treatment of Helicobacter pylori infection 224
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. 221
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments 219
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification 217
The Pneumococcal surface protein C (PspC) influences the susceptibility of Streptococcus pneumoniae to microglia 217
Mutants of Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. 215
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity 214
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G 214
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 214
Safety and immunogenicity in animals of subunit influenza vaccine given intranasally with mutants of Escherichia coli heat-labile enterotoxin (LT) 210
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 209
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery 205
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 204
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin 204
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 203
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 201
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform 200
Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: Safety, immunogenicity, and efficacy 200
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 199
Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans 199
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine 198
Physicochemical characterisation of the pertussis vaccine. 193
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 193
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 193
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 192
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis 191
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. 188
Immunobiological characterization of genetic products, identified from whole genome lambda-display libraries of Pneumococcus 187
Alterazione delle difese monocito-mediate nei confronti di miceti in presenza di virus erpetici 187
Alterazione delle difese monocito-mediate nei confronti di Cryptococcus neoformans in presenza dell’Herpesvirus umano 6 186
Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy 184
Attenuation of Pseudomonas aeruginosa Virulence by Pomegranate Peel Extract 183
IL MICROARRAY PROTEICO NELL’ANALISI DEI LIQUIDI AMNIOTICI: RICERCA DI MARKER PRECOCI DI INFIAMMAZIONE E/O INFEZIONE CORRELABILI AL PARTO PRETERMINE 182
The Spr1875 protein of Streptococcus pneumoniae protects the bacterium from microglia-mediated killing 182
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 177
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis 176
Interaction of pneumococcal surface structures with microglia 176
Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery 172
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 171
Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizaztion 169
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 169
RUOLO DI PRODOTTI GENICI IDENTIFICATI MEDIANTE LIBRERIE LAMBDA-DISPLAY DA GENOMA COMPLETO DI PNEUMOCOCCO NELL’INTERAZIONE IN VITRO CON CELLULE MICROGLIALI ED EPITELIALI 167
Bordetella 166
Risposta differenziale della cellula di microglia ad isolati clinici di Candida albicans con differente genotipo 165
LA PROTEINA SPR1875 DI STREPTOCOCCUS PNEUMONIAE PROTEGGE IL BATTERIO DAL KILLING DELLA MICROGLIA 163
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 161
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment. 160
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children 154
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity 154
Brucella 150
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 148
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 146
The polisaccharyde capsule is necessary for the development of fatal pneumococcal meningitis in mice 142
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K 142
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 138
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 136
Haemophilus 132
Totale 37.935
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.170 0 0 0 0 0 417 271 333 214 390 301 244
2021/20222.991 187 281 219 250 168 192 194 209 273 206 437 375
2022/20234.240 398 344 313 375 465 519 210 412 470 152 257 325
2023/20242.432 220 236 218 204 364 203 222 207 96 112 130 220
2024/20255.361 228 167 110 360 1.049 735 404 362 561 203 527 655
2025/20265.695 620 472 686 1.584 2.161 172 0 0 0 0 0 0
Totale 39.814